Your account is not claimed yet. You can sign up with ORCID to claim your account.

Eugenie S Kleinerman (Eugenie Kleinerman)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Cancers

Sarcoma

Clinical cancer research : an official journal of the American Association for Cancer Research

University of Texas M.D. Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas M.D. Anderson Cancer Center

United States

Professor :: Pediatrics

Publications

Prince Jeyabal, Anchit Bhagat, Fei Wang, Michael E Roth, Jonathan A Livingston, Susan C Gilchrist, Jose Banchs, Michelle A T Hildebrandt, Joya Chandra, Anita Deswal, Efstratios Koutroumpakis, Jian Wang, Najat C Daw, Theresa A Honey, Eugenie S Kleinerman
Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yuanzheng Yang, Zhanglong Peng, Elsa R Flores, Eugenie S Kleinerman
Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming. Cancers 14 (17) (2022)
Anchit Bhagat, Pradeep Shrestha, Eugenie S Kleinerman
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. International journal of molecular sciences 23 (23) (2022)
Anchit Bhagat, Pradeep Shrestha, Eugenie S Kleinerman
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. International journal of molecular sciences 23 (23) (2022)
Anchit Bhagat, Pradeep Shrestha, Eugenie S Kleinerman
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. International journal of molecular sciences 23 (23) (2022)
Anchit Bhagat, Pradeep Shrestha, Eugenie S Kleinerman
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. International journal of molecular sciences 23 (23) (2022)
Rong-Hua Tao, Masato Kobayashi, Yuanzheng Yang, Eugenie S Kleinerman
Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis. Cancers 13 (11) (2021)
Kerri Wolf-Dennen, Nancy Gordon, Eugenie S Kleinerman
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions. Oncoimmunology 9 (1) (2020)
Zhichao Zhou, Yuanzheng Yang, Fei Wang, Eugenie S Kleinerman
Neuronal Repressor REST Controls Ewing Sarcoma Growth and Metastasis by Affecting Vascular Pericyte Coverage and Vessel Perfusion. Cancers 12 (6) (2020)
Vivek Subbiah, Pete M Anderson, Kalevi Kairemo, Kenneth Hess, Winston W Huh, Vinod Ravi, Najat C Daw, Neeta Somaiah, Joseph A Ludwig, Robert S Benjamin, Sant Chawla, David S Hong, Funda Meric-Bernstam, Gregory Ravizzini, Eugenie S Kleinerman, Homer Macapinlac, Eric Rohren
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (13) (2019)
Eugenie S Kleinerman, Ling Yu, Jasmine Dao, Andrea A Hayes-Jordan, Brock Lindsey, Jitesh D Kawedia, John Stewart, Nancy Gordon
Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing. Sarcoma 2018 (2018)
Justin E Markel, Jabeen Noore, Eric J Emery, Harley J Bobnar, Eugenie S Kleinerman, Brock A Lindsey
Using the Spleen as an In Vivo Systemic Immune Barometer Alongside Osteosarcoma Disease Progression and Immunotherapy with α-PD-L1. Sarcoma 2018 (2018)

Eugenie S Kleinerman.css-eqlu8i{font-size:small;padding-left:4px;} (Eugenie Kleinerman)

Publication Activity (10 Years)

Top Topics

Top Venues

Eugenie S Kleinerman (Eugenie Kleinerman)